607 related articles for article (PubMed ID: 22181693)
21. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
[TBL] [Abstract][Full Text] [Related]
22. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Pfister WR
Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
24. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
[TBL] [Abstract][Full Text] [Related]
26. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
27. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
Baran R
Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
29. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study.
Gupta AK;
J Drugs Dermatol; 2005; 4(4):481-5. PubMed ID: 16004022
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
Tausch I; Bräutigam M; Weidinger G; Jones TC
Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
Jellinek NJ; Korotzer A
J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
[TBL] [Abstract][Full Text] [Related]
32. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
Vlahovic TC; Joseph WS
J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
[TBL] [Abstract][Full Text] [Related]
33. Short term treatment of dermatophyte onychomycosis with terbinafine.
Goodfield MJ; Andrew L; Evans EG
BMJ; 1992 May; 304(6835):1151-4. PubMed ID: 1392793
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
Zalacain-Vicuña AJ; Nieto C; Picas J; Martínez H; Bermejo R; Corrales A; Campos FF; Igea SA; Otero-Espinar FJ; Briones VG
Mycoses; 2023 Jul; 66(7):566-575. PubMed ID: 36336989
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
Yadav P; Singal A; Pandhi D; Das S
Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
[TBL] [Abstract][Full Text] [Related]
36. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
37. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Lecha M
Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
[TBL] [Abstract][Full Text] [Related]
38. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Gupta AK; Ryder JE; Johnson AM
Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
[TBL] [Abstract][Full Text] [Related]
39. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
[TBL] [Abstract][Full Text] [Related]
40. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
Avner S; Nir N; Henri T
J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
